/Apriori Bio and A*STAR Infectious Diseases Labs Announce Strategic Partnership to Advance Next Generation Influenza Vaccines
NEWS

Apriori Bio and A*STAR Infectious Diseases Labs Announce Strategic Partnership to Advance Next Generation Influenza Vaccines

PRNewswire
2025/11/18

ASTAR

Apriori Bio (PRNewsfoto/Flagship Pioneering)

Summary

/PRNewswire/ -- Apriori Bio, a Flagship Pioneering company focused on developing prospective, variant-resilient vaccines, and the Agency for Science,...